Evaluation of Aflibercept effect on VEGF gene expression in CAFs and CAFs/epithelial cells of Oral Squamous Cell Carcinoma
Publish place: First Personal Medical Congress
Publish Year: 1395
نوع سند: مقاله کنفرانسی
زبان: English
View: 449
نسخه کامل این Paper ارائه نشده است و در دسترس نمی باشد
- Certificate
- من نویسنده این مقاله هستم
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
IPMCMED01_127
تاریخ نمایه سازی: 23 آذر 1397
Abstract:
Introduction: Oral cancer is the tenth most common cancer in Iran. The main reason of poor prognosis is early, distant metastasis. Recent investigations show tumor stroma and especially Cancer-Associated Fibroblasts (CAFs) have a considerable role in angiogenesis and consequently tumor progression. In the present study we investigated and compared the anti-angiogenic impact of Aflibercept (Anti-cancer drug) in both CAFs and CAFs/epithelial cells co-culture.Materials and Methods: After obtaining tissue samples from an oral cancer patient, CAFs and CAFs/epithelial cells were isolated using enzymatic digestion and explant culture. VEGF gene expression were investigated using Real-Time PCR before and after treatment by Aflibercept.Results: VEGF gene expression was significantly increased in CAFs/epithelial cells co-culture comparing with CAFs. After treatment by Aflibercept, although VEGF gene expression was decreased, it was not significant.Conclusion: Although Aflibercept may confine oral squamous cell carcinoma progression through decreasing VEGF gene expression, it seems other molecular factors interfere this process.
Keywords:
Authors
Masoumeh Mirkeshavarz
Department of Oral and Maxillofacial Pathology, School of Dentistry, Tehran University of Medical Sciences
Ahmad Nasimian
Human and Animal cell Bank, Iranian Biological Resource Center (IBRC), ACECR
Pouyan Aminishakib
Department of Oral and Maxillofacial Pathology, School of Dentistry, Tehran University of Medical Sciences
Meysam Ganjibakhsh
Human and Animal cell Bank, Iranian Biological Resource Center (IBRC), ACECR